Research of complementary/alternative medicine therapies in oncology: promising but challenging.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Oncology

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 10630261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments.

  1999cited by this paper
• Coley toxins immunotherapy: a retrospective review.

  1999cited by this paper
• Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.

  1999cited by this paper
• Use of alternative medicine by women with early-stage breast cancer.

  1999cited by this paper
• Rationale for Drug Development of Herbals in Oncology: Clinical, Industry, and Regulatory Perspectives

  1999cited by this paper
• Alternative care. Patient choices for adjunct therapies within a cancer center.

  1998cited by this paper
• Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line.

  1998cited by this paper
• The prevalence of complementary/Alternative medicine in cancer

  1998cited by this paper
• Searching online and Web-based resources for information on natural products used as drugs.

  1998cited by this paper
• Unconventional therapies for cancer: a refuge from the rules of evidence?

  1998cited by this paper
• Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

  1998cited by this paper
• Alternative medicine meets science.

  1998cited by this paper
• Alternative medicine--the risks of untested and unregulated remedies.

  1998cited by this paper
• Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations.

  1998cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998cited by this paper
• Recruitment for complementary/alternative medicine trials: WHO participates after breast cancer

  1998cited by this paper
• The arrogance of science and the pitfalls of hope.

  1998cited by this paper
• Let's abolish the Office of Alternative Medicine of the National Institutes of Health.

  1998cited by this paper
• Why patients use alternative medicine: results of a national study.

  1998cited by this paper
• How Should we Research Unconventional Therapies? A Panel Report from the Conference on Complementary and Alternative Medicine Research Methodology, National Institutes of Health

  1997cited by this paper
• Cancer & Natural Medicine: A Textbook of Basic Science and Clinical Research

  1995cited by this paper
• Evidence and alternative medicine.

  1995cited by this paper
• Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer

  1994cited by this paper
• Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

  1993cited by this paper
• National Cancer Institute's evaluation of unconventional cancer treatments.

  1992cited by this paper
• The prevalence of questionable methods of cancer treatment in the United States

  1992cited by this paper
• Alternative therapies, 1990: An overview

  1991cited by this paper
• Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners.

  1984cited by this paper

• Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1.

  2022cites this paper
• The Autophagy-Inducing Mechanisms of Vitexin, Cinobufacini, and Physalis alkekengi Hydroalcoholic Extract against Breast Cancer in vitro and in vivo

  2021cites this paper
• The Therapeutic Efficacy of Physalis Alkekengi Hydro alcoholic Extract on Estrogen Receptor-Positive Breast Cancer Mice Model in an Autophagy Manner

  2020cites this paper
• Psycho-Oncology for the Clinician: The Patient Behind the Disease

  2019influential citation
• Treatments and Interventions in Cancer

  2019cites this paper
• Complementary and Alternative Medicine Use among Turkish Cancer Patients and the Influencing Factors

  2018cites this paper
• Antiproliferative and Apoptotic Effects of Shemamruthaa, a Herbal Preparation, in 7,12-Dimethylbenz(a)Anthracene-Induced Breast Cancer Rats

  2015cites this paper
• What is the impact of psychotherapy on cancer patient's survival?

  2014cites this paper
• No stone left unturned: challenges encountered during recruitment of women with advanced ovarian cancer for a phase I study.

  2013cites this paper
• Complementary and alternative medicine use among cancer patients at the end of life: Korean national study.

  2012cites this paper
• Classification of B-cell non-Hodgkin's lymphomas (NHL)

  2011cites this paper
• 3 q 27 rearrangements in non Hodgkin lymphoma , t ( 3 ; Var ) ( q 27 ; Var ) in non Hodgkin lymphoma

  2011cites this paper
• 3q27 rearrangements in non Hodgkin lymphoma, t(3;Var)(q27;Var) in non Hodgkin lymphoma

  2011cites this paper
• Healing Ourselves and Healing Our Communities

  2009cites this paper
• Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology

  2008cites this paper
• Characterization and expression of a maternal axolotl Cyclin B1 during oogenesis and early development

  2007cites this paper
• Folate and colorectal cancer: an evidence-based critical review.

  2007cites this paper
• Factors Influencing Complementary and Alternative Medicine Use in a Multisite Pediatric Oncology Practice

  2007cites this paper
• Translational control of maskin mRNA by its 3′ untranslated region

  2007cites this paper
• International Seminars in Surgical Oncology the Use of Complementary and Alternative Medicine by Cancer Patients

  2007cites this paper
• International Seminars in Surgical Oncology the Use of Complementary and Alternative Medicine by Cancer Patients

  2007cites this paper
• The use of complementary and alternative medicine by cancer patients

  2007cites this paper
• Pioderma gangrenoso bolhoso e síndrome mielodisplásica

  2006cites this paper
• The Use of Verbal Classification for Determining the Course of Medical Treatment by Medicinal Herbs

  2005cites this paper
• Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.

  2005cites this paper
• The use of complementary and alternative therapies by cancer patients in northern Israel.

  2005cites this paper
• Nationwide survey on complementary and alternative medicine in cancer patients in Japan.

  2005cites this paper
• Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy–induced mucositis and neutropenia

  2004cites this paper
• Effects of St. John's Wort and Vitamin E on Breast Cancer Chemotherapeutic Agents

  2003cites this paper
• Scutellaria baicalensis extract decreases cisplatin-induced pica in rats

  2003cites this paper
• Complementary, alternative, integrative, or unconventional medicine?

  2001cites this paper
• Traditional and alternative therapies for breast cancer.

  2001cites this paper
• Assessment of Outcomes at Alternative Medicine Cancer Clinics: A Feasibility Study

  2001cites this paper
• Determinants of the use of complementary therapies by patients with cancer.

  2001cites this paper